[ET Net News Agency, 25 August 2026] INNOGEN-B (02591) fell 4.3% to HK$3.89.
It hits an intra-day low of HK$3.89, hitting a historical low, and an intra-day high of HK$4.155. The total shares traded was 4.48 million, with a value of HK$17.88m. The active buy/sell ratio is 32:68, with net selling turnover of HK$6.13m. CHINA INV INFO accounts for greatest net responsive buying turnover of HK$3.18m, with volume weighted average price of HK$3.985. CITIC SEC BRO accounts for greatest net responsive selling turnover of HK$1.08m, with volume weighted average price of HK$3.97. The stock has fallen a combined 46% over the past 10 consecutive trading days.
Basic Information| Nominal | 3.890 | % Chg | -4.30% |
| High | 4.155 | Low | 3.890 |
| Shares Tr | 4.48m | Turnover | 17.88m |
| 10-D SMA | 5.054 | %H.V | 118.981 |
| 20-D SMA | 6.158 | VWAP | 3.994 |
| 50-D SMA | 7.201 | RSI14 | 19.723 |
Status: Hitting a historical low, active buy/sell ratio is 32:68, with net selling turnover of HK$6.13m, falling a combined 46% over the past 10 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| INNOGEN-B (02591) | 3.89 | -4.30 |
| GENSCRIPT BIO (01548) | 34.74 | +6.50 |
| INNOVENT BIO (01801) | 100.20 | +0.70 |
| EVEREST MED (01952) | 33.90 | +9.00 |
| XTALPI (02228) | 7.53 | +2.10 |
| WUXI XDC (02268) | 78.55 | +12.54 |
| WUXI BIO (02269) | 50.50 | +3.91 |
| BEONE MEDICINES (06160) | 222.60 | +0.54 |
| AKESO (09926) | 88.15 | -0.23 |
| REMEGEN (09995) | 78.45 | +5.73 |
(ed)
Nominal 
